Publication | Closed Access

Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment

Medicinal ChemistryNovel Resorcinol BiphenylBenign Toxicity ProfilesMedicineNatural SciencesPharmacotherapyAnti-cancer AgentCancer TreatmentDrug DevelopmentPharmacologyRadiation OncologySmall MoleculesDrug Discovery